Fate mapping via CCR2-CreER mice reveals monocyte-to-microglia transition in development and neonatal stroke.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32923636.
- Also identified by DOI 10.1126/sciadv.abb2119 and PMC identifier 7449686.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Whether monocytes contribute to the brain microglial pool in development or after brain injury remains contentious. To address this issue, we generated CCR2-CreER mice to track monocyte derivatives in a tamoxifen-inducible manner. This method labeled Ly6C<sup>hi</sup> and Ly6C<sup>lo</sup> monocytes after tamoxifen dosing and detected a surge of perivascular macrophages before blood-brain barrier breakdown in adult stroke. When dosed by tamoxifen at embryonic day 17 (E17), this method captured fetal hematopoietic cells at E18, subdural Ki67<sup>+</sup> ameboid cells at postnatal day 2 (P2), and perivascular microglia, leptomeningeal macrophages, and Iba1<sup>+</sup>Tmem119<sup>+</sup>P2RY12<sup>+</sup> parenchymal microglia in selective brain regions at P24. Furthermore, this fate mapping strategy revealed an acute influx of monocytes after neonatal stroke, which gradually transformed into a ramified morphology and expressed microglial marker genes (Sall1, Tmem119, and P2RY12) for at least 62 days after injury. These results suggest an underappreciated level of monocyte-to-microglia transition in development and after neonatal stroke.
Medical subject headings
- Microglia
- Stroke